Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

He says he wants to 'Make America Healthy Again,' but Donald Trump's pick to lead one of the nation's top public safety ...

Samsung Bioepis, a biopharmaceutical developer under Samsung Group, announced on Nov. 27 that Kim Kyung-Ah, head of its ...

In today’s fast-paced world, maintaining optimal health and peak performance is more important than ever. Many individ ...

At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...